Company Filing History:
1 out of 37 
1 out of 894 
Years Active: 2019
Title: Abed Nasereddin: Innovator in Antiprotozoal Compounds
Introduction
Abed Nasereddin is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antiprotozoal activity. His work focuses on addressing diseases caused by parasites, including malaria.
Latest Patents
Nasereddin holds a patent for "Indole compounds having antiprotozoal activity and its use as well as methods for producing the same." This invention relates to new bisindolylcyclobuten-dione-based structures that exhibit antiprotozoal properties. The patent outlines pharmaceutical compositions containing these compounds and their application in the prophylaxis and treatment of parasite-based diseases, including malaria.
Career Highlights
Throughout his career, Nasereddin has worked with esteemed institutions such as Technische Universität Braunschweig and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His innovative research has contributed to advancements in the treatment of parasitic infections.
Collaborations
Nasereddin has collaborated with notable colleagues, including Conrad Kunick and Hoang Lande. Their joint efforts have furthered the understanding and development of antiprotozoal therapies.
Conclusion
Abed Nasereddin's work in the field of antiprotozoal compounds highlights his commitment to addressing critical health challenges. His innovative contributions continue to pave the way for advancements in pharmaceutical treatments for parasitic diseases.